TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ZBIO

Zenas BioPharma, Inc.

Healthcare · Biotechnology

28.30$ +1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ZBIO
Line item 2022 2023 2024 2025
– – -90.0% +100.0%
– -99.8% +123,031.9% -100.0%
– – -368.3% –
– -4.2% +131.8% +20.8%
– +33.6% +68.6% +84.8%
– +500.6% -65.9% +644.2%
– – – –
– – – –
– – – –
– – +42.5% -118.4%
– – – –
– – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?